1. Huang C, Melnick A.Mechanisms of action of BCL6 during germinal center B cell development.Science China Life sciences,2015,58(12): 1226-1232. [Link]
2. Huang C, Shi Y, Zhao Y.USP8 mutation in Cushings disease.Oncotarget ,2015,6(21): 18240-18241. [Link]
3. Ma ZY, Chen JH, Song ZJ, Huang C, Shi YY and Zhao Y.Recurrent gain-of-function USP8 mutations in Cushing’disease.Cell Res,2015,25(3):306-17. [Link]
4. Huang C, Gonzalez DG, Cote CM, Jiang Y, Hatzi K, Teater M, Dai K, Hla T, Haberman AM, Melnick A.The BCL6 RD2 Domain Governs Commitment of Activated B Cells to Form Germinal Centers..Cell Reports,2014,8(5):1497-508. [Link]
5. Huang C, Geng H, Boss I, Wang L, Melnick AM.Cooperative transcriptional repression by BCL6 and BACH2 in germinal centre B-cell differentiation.Blood,2014,123(7):1012-20. [Link]
6. Huang C, Hatzi K, Melnick AM.Lineage-specific functions of Bcl6 in immunity and inflammation are mediated through distinct biochemical mechanisms.Nature Immunology ,2013,14(4): 380-8. [Link]
7. Swaminathan S, Huang C, Geng H, Chen Z, Harvey R, Kang H, Carina Ng, Titz B, Hurtz C, Sadiyah F, Melnick AM, Müschen M.BACH2 mediates negative ion and p53-dependent tumor suppression at the pre-B cell receptor checkpoint.Nature Medicine,2013,19(8):1014-22. [Link]
8. Sun Z, Huang C, He J, Lamb, Kristy L Kang X Shen WH Yin, Y.PTEN C-terminal deletion causes genomic instability and tumor development.Cell Reports,2014,6(5):844-54. [Link]
9. Hatzi K, Jiang Y, Huang C, Garrett-Bakelman F, Gearhart MD, GElemento O, Melnick A.A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters..Cell Reports,2013,15;4(3):578-88. [Link]
10. Cubedo E, Gentles AJ, Huang C, Natkunam, Y, Melnick A; Lossos IS.Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma.Blood,2012,119(23): 5478-5491. [Link]
